|3,500||estimated research jobs|
|$1.5||CDN billion estimated in sales|
|85||centers, research chairs, clusters and institutes|
Data compiled for the Québec City metropolitan region
With a state-of-the-art expertise in biopharmaceuticals, diagnostics, natural health products (cosmeceuticals and nutraceuticals), medical technologies and information technologies related to health, the Québec City metropolitan region is ideally positioned for a growing market. The global market of pharmaceutical products alone should double before 2020 to reach CDN $1.8 billion (PricewaterhouseCoopers 2010)-and the life sciences industry in the Québec City metropolitan region is set to reap the benefits.
The Québec City metropolitan region is distinguished by leaders and innovative companies with state-of-the-art expertise:
With a thriving life sciences industry, the Québec City metropolitan region benefits from ongoing and future investments (2010):
According to KPMG's 2010 Competitive Alternatives report, operating costs in the Québec City metropolitan region are lower than the average for North American cities in clinical trials (27%), biomedical R&D (20%) and manufacturing pharmaceuticals (6 %)-making it #1 in Canada and the United States.